Mulmit

CytomX Therapeutics, Inc.CytomX Therapeutics, Inc.

CTMX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3176,201,000-22,364,000-17,368,000
2024-12-31138,103,00024,995,00031,869,000
2023-12-31101,214,000-6,484,000-569,000
2022-12-3153,163,000-101,335,000-99,317,000
2021-12-3137,312,000-116,042,000-115,870,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-03Carvajal AlejandraChief Legal Officer100,000
2026-08-03Carvajal AlejandraChief Legal Officer450,000
2026-07-24Fuchs Charles S.118,000
2026-06-17Su Zhen59,000
2026-06-17Young Matthew P.59,000
2026-06-17Mohindru Mani59,000
2026-06-17Meyers James R59,000
2026-06-17Gilbert Halley E59,000
2026-06-17Ashworth Alan59,000
2026-06-17Jones Elaine V59,000
2026-06-15Ogden ChristopherChief Financial Officer1,624
2026-03-17Chu Yu-WayeChief Medical Officer21,279

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-07-27Officer or director change
2026-06-22Officer or director change · Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-06-03Entry into a material agreement
2026-05-07Results of operations · Financial statements and exhibits
2026-03-19Other events · Financial statements and exhibits
2026-03-16Results of operations · Financial statements and exhibits
2025-11-06Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.